The latest update is out from BioRestorative Therapies ( (BRTX) ).
In an effort to streamline its stock offering processes, the Company has terminated its previous agreement with JonesTrading, under which it had the flexibility to sell shares worth up to $6.1 million. Before terminating this arrangement in November 2024, the Company successfully sold $622,235 worth of its common stock.
For an in-depth examination of BRTX stock, go to TipRanks’ Stock Analysis page.
